Be Pharmaceuticals recalls

2 official recalls and safety alerts involving Be Pharmaceuticals since 2023-09, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Be Pharmaceuticals or the relevant agency.

1. 2024-01-31
2. US
   Drugs & medicalClass II

   BE PHARMACEUTICALS AG recalls Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single…

   Lack of Sterility Assurance: Aseptic process simulation failure.

   FDA · DrugBE PHARMACEUTICALS AGNationwide in the USAOfficial notice →
3. 2023-09-20
4. US
   Drugs & medicalClass II

   BE PHARMACEUTICALS AG recalls Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC…

   Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

   FDA · DrugBE PHARMACEUTICALS AGNationwide in the USAOfficial notice →